for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Johnson & Johnson

JNJ

Latest Trade

170.22USD

Change

0.26(+0.15%)

Volume

5,797,704

Today's Range

170.17

 - 

171.61

52 Week Range

133.65

 - 

173.65

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
169.96
Open
171.48
Volume
5,797,704
3M AVG Volume
161.31
Today's High
171.61
Today's Low
170.17
52 Week High
173.65
52 Week Low
133.65
Shares Out (MIL)
2,633.40
Market Cap (MIL)
448,256.70
Forward P/E
17.86
Dividend (Yield %)
2.49

Next Event

Dividend For JNJ.BA - 0.2120 USD

Latest Developments

More

U.S. CDC Says Administered 270.8 Mln Doses Of COVID-19 Vaccine As Of May 15

U.S. CDC Says Delivered 341.9 Million Doses Of Covid-19 Vaccine As Of May 14

U.S. CDC Says Delivered 339,165,445 Doses Of Covid-19 Vaccine As Of May 13 Versus 337,089,765 Doses Delivered As Of May 12

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Industry

Biotechnology & Drugs

Contact Info

1 Johnson And Johnson Plz

NEW BRUNSWICK, NJ

08933-0001

United States

+1.732.5242455

https://www.jnj.com/

Executive Leadership

Alex Gorsky

Chairman of the Board, Chief Executive Officer

Paulus A. Stoffels

Vice Chairman- Executive Committee, Chief Scientific Officer

Joaquin Boix Duato

Vice Chairman - Executive Committee

Joseph J. Wolk

Chief Financial Officer, Executive Vice President

Peter M. Fasolo

Chief Human Resource Officer, Executive Vice President

Key Stats

1.94 mean rating - 18 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

81.6K

2019

82.1K

2020

82.6K

2021(E)

91.3K
EPS (USD)

2018

8.180

2019

8.680

2020

8.030

2021(E)

9.529
Price To Earnings (TTM)
30.07
Price To Sales (TTM)
5.32
Price To Book (MRQ)
6.81
Price To Cash Flow (TTM)
19.93
Total Debt To Equity (MRQ)
51.06
LT Debt To Equity (MRQ)
45.97
Return on Investment (TTM)
11.95
Return on Equity (TTM)
9.23

Latest News

Latest News

U.S. CDC finds more clotting cases after J&J vaccine, sees causal link

The U.S. Centers for Disease Control and Prevention said on Wednesday it had found more cases of potentially life-threatening blood clotting among people who received the Johnson & Johnson COVID-19 vaccine and sees a "plausible causal association."

Norway drops AstraZeneca vaccine, J&J remains on hold

Norway will not resume use of the COVID-19 vaccine made by AstraZeneca, and a decision on whether to include Johnson & Johnson shots in its mass inoculation scheme remains on hold, Prime Minister Erna Solberg said on Wednesday.

Norway drops AstraZeneca vaccine, J&J remains on hold

Norway will not resume the use of COVID-19 vaccines made by AstraZeneca, while a decision on whether to start using inoculations made by Johnson & Johnson's remains on hold, Prime Minister Erna Solberg said on Wednesday.

U.S. CDC says identified 28 blood clotting cases after J&J vaccine

The U.S. Centers for Disease Control and Prevention said on Wednesday that it had identified 28 cases of serious blood clotting among the more than 8.7 million people who had received the Johnson & Johnson COVID-19 vaccine.

Bolivia signs J&J vaccine deal with a twist - it needs WTO patent waiver

Bolivia's government said on Tuesday it had signed a deal for a potential 15 million Johnson & Johnson COVID-19 vaccines but with a twist: another manufacture would make the shots and Bolivia would need the World Trade Organization to waive the drug's patent.

Bolivia signs J&J vaccine deal with a twist: someone else would make it

Bolivia's government said on Tuesday it had signed a deal for a potential 15 million Johnson & Johnson COVID-19 vaccines but with a twist: another manufacture would make the shots and the country would need the World Trade Organization to waive the drug's patent.

Spain approves J&J COVID vaccine for under 60s - El Pais

Spain approved on Tuesday the use of Johnson & Johnson's COVID-19 vaccine for people under the age of 60, Spanish El Pais newspaper reported, citing regional government sources.

Fact Check-Blank Johnson & Johnson vaccine insert is not proof the company is hiding safety and efficacy information

Suggestions that Johnson & Johnson has included blank inserts in medical packaging to conceal the safety and efficacy information of its COVID-19 vaccine are false. The insert was intentionally left blank – and it includes a QR code and website to see the most up-to-date...

Norway should exclude J&J, AstraZeneca from vaccine scheme - panel

Norway should exclude the COVID-19 vaccines made by AstraZeneca and Johnson & Johnson from its inoculation programme due to a risk of rare but harmful side-effects, a government-appointed commission said on Monday.

Italy's Lazio region urges people to take AstraZeneca, J&J shots

Italy's Lazio region, centred on the capital Rome, is urging people to book AstraZeneca and Johnson & Johnson COVID-19 shots, which have fallen out of favour with some residents over worries about possible side effects.

Germany to make J&J's COVID-19 vaccine available to all adults

Germany is to make Johnson & Johnson's COVID-19 vaccine available to all adults, Health Minister Jens Spahn said on Monday, adding that they will be able to receive the shot on the advice of a doctor.

Norway should exclude J&J, AstraZeneca from COVID vaccination scheme, says commission

Norway should exclude the COVID-19 vaccines made by AstraZeneca and Johnson & Johnson in its inoculation program due to a risk of rare but harmful side-effects, a government-appointed commission said on Monday.

Germany to lift prioritisation for J&J COVID-19 vaccine

Germany is lifting the prioritisation for giving Johnson & Johnson's COVID-19 vaccine, Health Minister Jens Spahn said on Monday, adding that any adult who wants it will be able to receive the shot on a doctor's advice.

German panel to recommend J&J COVID vaccine for over-60s - Spiegel

Germany's vaccine committee, known as STIKO, plans to recommend Johnson & Johnson's COVID-19 vaccine only for people over the age of 60, German magazine Der Spiegel reported on Friday, citing no sources.

Germany's STIKO to recommend J&J COVID vaccine for over-60s - Spiegel

Germany's vaccine committee, known as STIKO, plans to recommend Johnson & Johnson's COVID-19 vaccine only for people over the age of 60, German magazine Der Spiegel reported on Friday, citing no sources.

Poland offers to buy J&J shots from Denmark

Poland has offered to buy Johnson & Johnson COVID-19 vaccines from Denmark, a government spokesman said on Wednesday, after Copenhagen excluded the shots from its vaccination programme over a potential link to blood clots.

Poland ready to buy J&J shots from Denmark, Polsatnews.pl reports

Poland is ready to buy Johnson & Johnson COVID-19 shots from Denmark, news portal Polsatnews.pl reported on Wednesday, citing a letter from Polish Prime Minister Mateusz Morawiecki to his Danish counterpart.

Poles give up grilling and drinking to queue for the J&J jab

For Poles, the May long weekend is usually a time for grilling, socializing and drinking. But in the middle of a pandemic, thousands decided to stand in the rain to get a Johnson & Johnson jab instead.

Denmark ditches J&J COVID-19 shots from vaccination programme

Denmark on Monday became the first country to exclude Johnson & Johnson's COVID-19 shots from its vaccination programme over a potential link to a rare but serious form of blood clot.

Denmark excludes J&J shot from vaccine programme - B.T. newspaper reports

Denmark has decided not to include the Johnson & Johnson COVID-19 shot in its vaccination programme, newspaper B.T. reported on Monday citing unnamed sources.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up